CTE — Cryosite Income Statement
0.000.00%
Last trade - 00:00- AU$36.61m
- AU$34.29m
- AU$12.61m
- 99
- 40
- 30
- 59
Annual income statement for Cryosite, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | C2021 June 30th | R2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 9.01 | 10 | 11.8 | 11.9 | 12.6 |
| Cost of Revenue | |||||
| Gross Profit | 4.04 | 5.89 | 6.84 | 7.17 | 7.99 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 7.25 | 8.81 | 9.88 | 10.4 | 10.6 |
| Operating Profit | 1.77 | 1.21 | 1.88 | 1.52 | 2.05 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1.77 | 1.12 | 1.81 | 1.57 | 2.09 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.48 | 0.653 | 1.36 | 1.41 | 1.84 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 1.48 | 0.653 | 1.36 | 1.41 | 1.84 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.48 | 0.653 | 1.36 | 1.41 | 1.84 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.014 | 0.014 | 0.028 | 0.029 | 0.038 |
| Dividends per Share |